Stay updated on PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page’s footer revision/version was updated from v3.5.2 to v3.5.3, indicating a minor update to the site itself rather than a change to the clinical trial study content.
    Difference
    0.1%
    Check dated 2026-04-25T18:54:26.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T14:36:13.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    50 days ago
    Change Detected
    Summary
    Page revision updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T21:25:16.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T19:50:02.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    The page now displays a new revision label: Revision: v3.4.2. This is a minor meta-update and does not alter study details or eligibility information.
    Difference
    0.1%
    Check dated 2026-02-12T02:22:00.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Revision: v3.4.1 added and v3.4.0 removed; this appears to be an internal version update with no changes to the page content or study information.
    Difference
    0.1%
    Check dated 2026-02-04T12:32:11.000Z thumbnail image

Stay in the know with updates to PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial page.